Why This Matters Now
The fundraising market in 2025 and 2026 has reset from its 2021 peak. Valuations are more disciplined. Investors are taking longer to close. Term sheets that would have been signed quickly in a loose market are being negotiated harder. Founders who do not understand the mechanics of what they are signing are at a structural disadvantage at the table.
SAFEs, convertible notes, and priced rounds each carry mechanics that determine how much of the company the founder will own after conversion, what rights investors hold, and how value is distributed at exit. These are not standard forms. Every clause is a negotiation with long-term consequences. The valuation cap, the discount rate, the liquidation preference, the anti-dilution provision: each of these decisions compounds over subsequent rounds.
The founders who protect their position through a fundraising process are not the ones who push hardest on every clause. They are the ones who understand which clauses actually matter, what the market standard is, and where deviation from that standard creates real risk.
Five Things Founders Get Wrong About Fundraising
1. Signing SAFEs Without Modelling the Conversion
A SAFE is not equity. It is a right to receive equity at a future price, subject to a valuation cap, a discount, or both. The actual dilution does not materialise until conversion, which happens at the next priced round. Founders who sign multiple SAFEs across different rounds without modelling the cumulative conversion often discover at Series A that they own significantly less than they expected. The paperwork is short. The math compounds silently.
2. Treating the Term Sheet as Non-Binding
Most term sheets are non-binding on price and structure. Founders sometimes treat this as meaning the term sheet does not matter. It does. The term sheet establishes the commercial framework that the definitive documents will follow. Renegotiating after a term sheet is signed is possible but expensive in time, relationship, and leverage. The moment to push back on valuation, option pool sizing, liquidation preference, and anti-dilution is before the term sheet is signed, not after.
3. Accepting Liquidation Preferences Without Understanding the Stack
A liquidation preference determines how proceeds are distributed at exit before common shareholders receive anything. A 1x non-participating preference is standard and founder-friendly. A participating preference, or a preference above 1x, can materially reduce founder economics at exit, particularly in mid-range outcomes. The preference does not only affect the investor who holds it. It affects every subsequent investor who sits below it in the stack.
4. Ignoring Anti-Dilution Provisions
Anti-dilution provisions protect investors against down rounds by adjusting the conversion price of their preferred shares. Broad-based weighted average anti-dilution is the market standard and relatively founder-friendly. Full ratchet anti-dilution is punitive: in a down round, it converts the investor's shares at the new lower price, creating severe dilution for founders and employees. Most founders do not model what full ratchet means for their cap table until it is too late to renegotiate.
5. Negotiating Every Clause Instead of the Right Ones
Not every clause in a term sheet has equal commercial significance. Founders who negotiate everything equally spend leverage on low-impact terms and lose it on high-impact ones. The clauses that actually determine long-term founder economics are valuation and option pool size, liquidation preference structure, anti-dilution mechanism, pro-rata rights, and information rights. Board composition and protective provisions determine control. Everything else is secondary. Knowing which battles to pick is the difference between a good outcome and a good process.
The Mechanics That Actually Determine Your Outcome
Every fundraising instrument and every term sheet clause has a specific commercial function. Understanding what each one does, and what it costs, is the foundation of any negotiation that produces a good outcome.
SAFEs and Convertible Notes
SAFEs and convertible notes are pre-priced instruments: they defer the equity conversation to a future priced round. A SAFE converts at the lower of a valuation cap or a discount to the Series A price. A convertible note does the same but carries interest and a maturity date. The key variables are the cap, the discount, and whether there is a most favoured nation clause that adjusts terms if a better deal is offered to a later investor. The dilution from these instruments does not appear on the cap table until conversion. That invisibility is where most founders miscalculate.
Priced Rounds and the Term Sheet
A priced round sets a valuation and issues shares at that price. The term sheet covers the pre-money valuation, the option pool, the share price, the investment amount, the type of preferred shares being issued, and the rights attached to them. The pre-money valuation and the option pool interact: an option pool increase before the round closes dilutes founders, not investors. A term sheet that shows a high pre-money valuation with a large pre-round option pool expansion may produce worse founder economics than a lower headline number with a smaller pool.
Liquidation Preferences
A liquidation preference determines who gets paid first and how much at exit or wind-down. A 1x non-participating preference means the investor takes back their investment before common shareholders receive anything, but then participates pro-rata. A participating preferred gets their money back and then participates in the remaining proceeds alongside common shareholders. The difference is most significant in mid-range exit outcomes, where a participating preference can substantially reduce what founders and employees receive.
Anti-Dilution Protection
Anti-dilution provisions adjust the conversion price of preferred shares if the company later raises at a lower valuation. Broad-based weighted average anti-dilution adjusts the conversion price based on the overall dilutive impact of the down round. Full ratchet adjusts the conversion price to the new lower price in full, regardless of the size of the down round. The difference in dilutive impact between these two mechanisms in a significant down round can be severe. Broad-based weighted average is the market standard for a reason.
Pro-Rata Rights and Information Rights
Pro-rata rights give investors the right to participate in future rounds to maintain their percentage ownership. For founders, this affects how much of a future round is available to new investors. Information rights define what financial and operational data investors are entitled to receive, and how frequently. Both sets of rights are standard in institutional rounds. The question is not whether to grant them but how broadly they are drafted and which investors hold them.
These mechanics do not operate in isolation. The valuation cap on a SAFE affects Series A dilution. The Series A liquidation preference affects Series B economics. Anti-dilution from Series A affects what founders hold at exit. Understanding how these elements interact across rounds is the analytical work that most founders delegate entirely and should not.
How J.A. Consulting Works on This
Fundraising legal work is not about reviewing documents after the commercial deal is done. It is about understanding the mechanics before the term sheet is signed, so the negotiation happens from a position of clarity rather than reaction.
Term Sheet Review and Negotiation Support
For founders who have received a term sheet and want to understand what it actually means before signing. This covers a clause-by-clause review of the commercial and governance terms, identification of deviations from market standard, and a clear picture of the economic and control consequences of the terms as drafted. The output is a negotiation strategy: which clauses to push back on, what to ask for, and where the investor is likely to move.
SAFE and Convertible Note Analysis
For founders who have issued or are about to issue SAFEs or convertible notes and want to understand the cumulative dilution before the next priced round. This covers modelling the conversion mechanics under different Series A scenarios, identifying how the cap and discount interact with the pre-money valuation, and producing a clear picture of post-conversion ownership before the round closes. The output is the analysis most founders wish they had run before the first SAFE was signed.
Investment Documentation Review
For founders going through a priced round and reviewing the definitive investment documents: the shareholders agreement, the subscription agreement, and the updated articles. This covers a review of the governance provisions, the protective provisions investors hold, the drag-along and tag-along mechanics, and the representations and warranties the company is making. The output is a clear understanding of what the company is agreeing to and where the non-standard positions are.
Cap Table and Dilution Modelling
For founders who want a clear picture of their current cap table and how it will evolve through future funding rounds. This covers a review of the current ownership structure, modelling of conversion from outstanding SAFEs and notes, option pool requirements, and the dilutive impact of future rounds under different valuation scenarios. The output is a cap table model the founder can use in investor conversations and internal planning.
For most founders, the right entry point is the term sheet review. Understanding what is in front of you before you sign it is the decision that determines everything that follows.
View all servicesGo Deeper
SAFE vs Series A: Choosing the Right Fundraising Instrument
When a SAFE preserves useful flexibility and when a priced round becomes the more disciplined choice. The mechanics of conversion, the dilution that does not appear until Series A, and the framework for deciding which instrument fits the stage and the relationship.
Liquidation Preference: The Term That Decides Who Really Benefits From the Exit
How liquidation preference shifts exit economics, especially in mid-range outcomes. The difference between participating and non-participating preferred, how the stack compounds across rounds, and what founders should push back on and what they should accept.
Anti-Dilution Protection: How a Down Round Reallocates Pain Across the Cap Table
The formula, the denominator, and the carve-outs that actually determine the outcome of a down round. The difference between broad-based weighted average and full ratchet, and why that difference matters more than most founders realise until it is too late to renegotiate.
Resources
SAFE vs Series A: Key Mechanics
A practical reference on the conversion mechanics of SAFEs and convertible notes, the variables that determine dilution, and the framework for choosing between a pre-priced instrument and a priced round.
Liquidation Preference: What It Means for Your Exit
A concise reference on liquidation preference structures, how participating and non-participating preferred affects founder economics at exit, and what market standard looks like across different round types.
Anti-Dilution: The Mechanics of a Down Round
A practical guide to anti-dilution provisions, the difference between broad-based weighted average and full ratchet, and how to model the dilutive impact before agreeing to the terms.